COMMUNIQUÉS West-GlobeNewswire

Raw Garden Launches Solventless Live Rosin Joints
10/07/2026
Unique Application Technique Delivers A Smoother, More Consistent Pre-Roll SANTA BARBARA, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Raw Garden , California’s leader in clean cannabis for over a decade, today announces [...]
FDA Proposes Rule to Modernize Drug Manufacturing Registration
10/07/2026
Proposed rule would streamline registration for advanced distributed manufacturers and increase visibility into foreign drug supply sources Silver Spring, MD, July 10, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
Sanofi: Information concerning the total number of voting rights and shares - June 2026
10/07/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin 2026
10/07/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques
10/07/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR SON PROGRAMME CLINIQUE AVEC L’ARRET DE CERTAINES ETUDES CLINIQUES NON PRIORITAIRES EN VUE DE SE CONCENTRER SUR DEUX PROGRAMMES CLINIQUES Paris, le 10 juillet 2026, 18h [...]
Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
10/07/2026
FORT LEE, N.J., July 10, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
Cosmos Health Launches Subscription Model
10/07/2026
Subscription model already launched with NOOR Collagen in the United States Early data shows a repeat purchase rate above 60% at high margins in excess of 50% Model is designed to drive stronger loyalty, greater [...]
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
10/07/2026
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL PROGRAMS Paris, July 10, 2026, 6pm CET AB Science SA (Euronext - FR0010557264 - [...]
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
10/07/2026
Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its [...]
PatchMD Adds a Topical Berberine Patch to Its Lineup
10/07/2026
The Las Vegas company that introduced the first vitamin patch in 2009 expands its metabolic line with a plant-based patch that delivers berberine and five supporting extracts through the skin. LAS VEGAS, NV, July 10, [...]
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
10/07/2026
Management to participate in investor meetings on July 14-15 in Boston Denver, CO, July 10, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical [...]
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
10/07/2026
Virtual Fireside Chat Scheduled for Tuesday, July 14, 2026, at 10:30 a.m. ET NORTH PALM BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled [...]
Grifols deaths and harm: Patient safety & options for accountability
10/07/2026
TORONTO, July 10, 2026 (GLOBE NEWSWIRE) -- Will Trial Lawyers and the Ontario Health Coalition invite members of the media to attend a press conference regarding patient safety issues related to Grifols, one of the [...]
Frishantic Launches Vitamin D3 K2 5000 IU Supplement for Indoor-Heavy Lifestyles
10/07/2026
A one-daily softgel formula designed to support bone health, normal immune function, and daily wellness for adults navigating modern indoor routines. NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- Frishantic , a wellness [...]
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
10/07/2026
Taipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and [...]
Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity
10/07/2026
BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrutinib, a BTK (Bruton [...]
Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care
10/07/2026
Dubai, United Arab Emirates, July 10, 2026 (GLOBE NEWSWIRE) -- Dubai Health has announced a strategic collaboration with Rush University System for Health, one of the leading United States-based academic healthcare [...]
Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable
10/07/2026
Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable Sarclisa Escena administrée à l’aide de l’injecteur [...]
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative
10/07/2026
Vancouver, Canada, July 10, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a biotech company developing novel, non-hallucinogenic, next-generation, neuroplastogen-derived therapeutics [...]

Pages